News Commentary | April 15, 2021
As the immediate life‑threatening concerns of COVID‑19 begin to wane due to vaccines, there is a growing need to address the long‑term health impacts of the pandemic. Cognitive deficits, especially brain fog, are emerging as a common long‑term symptom. Akili is exploring its current offering for ... Not part of subscription
Analyst Insight | May 19, 2021
Chronic Kidney Disease (CKD) The digital transformation of healthcare is enabling more effective ways of managing disease, and chronic kidney disease is no exception. The U.S. CDC estimates that 40% of people with severely reduced kidney function do not know they have it, as the symptoms are ... Not part of subscription
News Commentary | June 10, 2021
Telehealth has represented big business during the COVID‑19 pandemic, and U.K.‑based Babylon Health is no exception. As temporary extensions for telehealth coverage expire in the U.S., Babylon will need to double down on human‑provided telehealth services (as opposed to chatbots and mHealth tools) ... Not part of subscription
by Danielle Bradnan
This is important not only for managing the COVID-19 crisis but also for establishing telehealth services in hospitals throughout the U.S. After this crisis has passed (and estimates for a vaccine are 18 months out), this equipment is not going to go away. Physicians and patients will have developed a comfort with these tools – and, coupled with access to equipment and a newly relaxed regulatory policy, many of the historical infrastructural hurdles to telehealth adoption will be removed. Clients should anticipate that telehealth is going to continue to grow and should look to invest in flavors of telehealth that support video conferencing, such as remote monitoring devices like AliveCor's cardiac monitor, mHealth, and digital therapeutics.
For the original news article, click here .